Baidu
map

CDE发布《药物临床试验中心化监查统计指导原则(征求意见稿)》公开征求意见通知

2021-09-17 CDE CDE

9月16日,国家药监局药审中心(CDE)发布《药物临床试验中心化监查统计指导原则(征求意见稿)》并公开征求意见通知。

9月16日,国家药监局药审中心(CDE)发布《药物临床试验中心化监查统计指导原则(征求意见稿)》并公开征求意见通知。通知称,这是为了呼应 ICH E6(R2)和我国药品监督管理局2020年发布的《药物临床试验质量管理规范》中均明确提出申办者应采用系统的、基于风险的方式对临床试验进行监查,并强调了中心化监查的优势。这将指导申办者对中心化监查的实践与应用,促进临床试验质量核查更加高效。

 
----

       ICH E6(R2)和我国药品监督管理局2020年发布的《药物临床试验质量管理规范》中均明确提出申办者应采用系统的、基于风险的方式对临床试验进行监查,并强调了中心化监查的优势。为了指导申办者对中心化监查的实践与应用,促进临床试验质量核查更加高效。我中心组织起草了《药物临床试验中心化监查统计指导原则(征求意见稿)》,现公开征求意见。欢迎社会各界提出宝贵意见和建议,并请及时反馈给我们。

       征求意见时限为自发布之日起1个月。

       请将您的反馈意见发到邮箱:王北琪 wangbq@cde.org.cn

       感谢您的参与和大力支持。

                                                                                                                                                            国家药品监督管理局药品审评中心

                                                                                                                                                                            2021年9月16日

 

参考资料:https://www.cde.org.cn/main/news/viewInfoCommon/e83d165520d9ab17004eb10ff39d2c24

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1949973, encodeId=7ae519499e3f8, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Mar 09 01:56:12 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009780, encodeId=457e2009e80a0, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Apr 09 08:56:12 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480950, encodeId=f0a214809503f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87648, encryptionId=96a08e64833, topicName=药物临床试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65ed7724096, createdName=1508842480_96220439, createdTime=Sun Sep 19 06:56:12 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052486, encodeId=6a9310524865b, content=你记错计算机死咯**片子, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Sep 18 06:55:13 CST 2021, time=2021-09-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1949973, encodeId=7ae519499e3f8, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Mar 09 01:56:12 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009780, encodeId=457e2009e80a0, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Apr 09 08:56:12 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480950, encodeId=f0a214809503f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87648, encryptionId=96a08e64833, topicName=药物临床试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65ed7724096, createdName=1508842480_96220439, createdTime=Sun Sep 19 06:56:12 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052486, encodeId=6a9310524865b, content=你记错计算机死咯**片子, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Sep 18 06:55:13 CST 2021, time=2021-09-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1949973, encodeId=7ae519499e3f8, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Mar 09 01:56:12 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009780, encodeId=457e2009e80a0, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Apr 09 08:56:12 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480950, encodeId=f0a214809503f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87648, encryptionId=96a08e64833, topicName=药物临床试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65ed7724096, createdName=1508842480_96220439, createdTime=Sun Sep 19 06:56:12 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052486, encodeId=6a9310524865b, content=你记错计算机死咯**片子, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Sep 18 06:55:13 CST 2021, time=2021-09-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1949973, encodeId=7ae519499e3f8, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Mar 09 01:56:12 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009780, encodeId=457e2009e80a0, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sat Apr 09 08:56:12 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480950, encodeId=f0a214809503f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87648, encryptionId=96a08e64833, topicName=药物临床试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65ed7724096, createdName=1508842480_96220439, createdTime=Sun Sep 19 06:56:12 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052486, encodeId=6a9310524865b, content=你记错计算机死咯**片子, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Sep 18 06:55:13 CST 2021, time=2021-09-18, status=1, ipAttribution=)]
    2021-09-18 查查佳佳

    你记错计算机死咯**片子

    0

Baidu
map
Baidu
map
Baidu
map